Financials Mabion S.A.

Equities

MAB

PLMBION00016

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 11:55:56 2024-04-26 am EDT 5-day change 1st Jan Change
16.5 PLN -0.12% Intraday chart for Mabion S.A. -2.94% -9.09%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2024 2025 2026
Capitalization 1 1,056 284.9 987.5 339.4 266.7 - -
Enterprise Value (EV) 1 1,050 319.2 958.2 291.9 244.5 243.5 242.9
P/E ratio -16.6 x -5.11 x 509 x 14.7 x - - -
Yield - - - - - - -
Capitalization / Revenue - - 17.4 x 2.07 x 2.37 x 2.4 x 1.86 x
EV / Revenue - - 16.8 x 1.78 x 2.17 x 2.19 x 1.69 x
EV / EBITDA -20.1 x -7.12 x -972 x 7.85 x 8.78 x 13.5 x 6.54 x
EV / FCF -24.4 x -8.27 x -14.8 x 13.2 x 85.8 x -36.3 x 18.5 x
FCF Yield -4.09% -12.1% -6.73% 7.57% 1.17% -2.75% 5.41%
Price to Book -49 x -4.1 x - - 2.11 x 1.99 x 1.74 x
Nbr of stocks (in thousands) 13,721 13,730 16,161 16,162 16,162 - -
Reference price 2 77.00 20.75 61.10 21.00 16.50 16.50 16.50
Announcement Date 4/8/20 4/30/21 4/21/22 4/18/23 - - -
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2024 2025 2026
Net sales 1 - - 56.87 164 112.7 111.3 143.7
EBITDA 1 -52.16 -44.82 -0.986 37.19 27.83 18.07 37.15
EBIT 1 -63.27 -54.65 -9.832 28.22 17.43 6.767 23.43
Operating Margin - - -17.29% 17.21% 15.47% 6.08% 16.31%
Earnings before Tax (EBT) 1 -63.74 -55.77 -10.26 22.04 4 6 -
Net income 1 -63.74 -55.77 1.903 23.19 4 6 -
Net margin - - 3.35% 14.14% 3.55% 5.39% -
EPS -4.640 -4.060 0.1200 1.430 - - -
Free Cash Flow 1 -42.97 -38.6 -64.52 22.11 2.85 -6.7 13.15
FCF margin - - -113.45% 13.48% 2.53% -6.02% 9.15%
FCF Conversion (EBITDA) - - - 59.44% 10.24% - 35.4%
FCF Conversion (Net income) - - - 95.33% 71.25% - -
Dividend per Share - - - - - - -
Announcement Date 4/8/20 4/30/21 4/21/22 4/18/23 - - -
1PLN in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2024 Q1
Net sales 1 38.64 43.91 38.48 42.95 39.5 36.03 29.58 47.4
EBITDA 1 9.635 5.619 -5.08 26.36 19.8 19.19 12.83 24.1
EBIT 1 7.102 3.095 -6.85 24.45 18 17.48 10.86 22.4
Operating Margin 18.38% 7.05% -17.8% 56.94% 45.57% 48.5% 36.7% 47.26%
Earnings before Tax (EBT) - - - - - - - -
Net income 1 - - - 15.69 16.5 15.24 10.86 21
Net margin - - - 36.54% 41.77% 42.31% 36.7% 44.3%
EPS - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 5/27/22 9/29/22 11/24/22 4/18/23 5/23/23 9/12/23 11/14/23 -
1PLN in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2024 2025 2026
Net Debt 1 - 34.3 - - - - -
Net Cash position 1 6.03 - 29.3 47.5 22.2 23.2 23.8
Leverage (Debt/EBITDA) - -0.7649 x - - - - -
Free Cash Flow 1 -43 -38.6 -64.5 22.1 2.85 -6.7 13.2
ROE (net income / shareholders' equity) -620% - - 35.7% 18.4% 3.8% 17.5%
ROA (Net income/ Total Assets) -49.4% - - - - - -
Assets 1 129.1 - - - - - -
Book Value Per Share 2 -1.570 -5.060 - - 7.830 8.300 9.490
Cash Flow per Share - - - - - - -
Capex 1 9.21 3.36 31.6 - 24 16.8 18.1
Capex / Sales - - 55.59% - 21.3% 15.04% 12.6%
Announcement Date 4/8/20 4/30/21 4/21/22 4/18/23 - - -
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
3
Last Close Price
16.5 PLN
Average target price
15.83 PLN
Spread / Average Target
-4.04%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MAB Stock
  4. Financials Mabion S.A.